Plexus (PLXS) reported $1.06 billion in revenue for the quarter ended September 2025, representing a year-over-year increase of 0.7%. EPS of $2.14 for the same period compares to $1.85 a year ago.
The reported revenue represents a surprise of +1.16% over the Zacks Consensus Estimate of $1.05 billion. With the consensus EPS estimate being $1.84, the EPS surprise was +16.3%.
While investors scrutinize revenue and earnings changes year-over-year and how they compare with Wall Street expectations to determine their next move, some key metrics always offer a more accurate picture of a company's financial health.
As these metrics influence top- and bottom-line performance, comparing them to the year-ago numbers and what analysts estimated helps investors project a stock's price performance more accurately.
Here is how Plexus performed in the just reported quarter in terms of the metrics most widely monitored and projected by Wall Street analysts:
- Revenue- Market Sector- Healthcare/Life Sciences: $424 million versus the two-analyst average estimate of $433.16 million. The reported number represents a year-over-year change of +2.2%.
- Revenue- Market Sector- Aerospace/Defense: $173 million versus the two-analyst average estimate of $183.12 million. The reported number represents a year-over-year change of -6%.
- Revenue- Market Sector- Industrial: $461 million compared to the $430.41 million average estimate based on two analysts. The reported number represents a change of +2% year over year.
View all Key Company Metrics for Plexus here>>>
Shares of Plexus have returned +3.4% over the past month versus the Zacks S&P 500 composite's +1.1% change. The stock currently has a Zacks Rank #3 (Hold), indicating that it could perform in line with the broader market in the near term.
Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report
Plexus Corp. (PLXS): Free Stock Analysis ReportThis article originally published on Zacks Investment Research (zacks.com).
Zacks Investment Research